Statistical Methods in Biomarker and Early Clinical Development
Editor
- Liang Fang(MyoKardia Inc.)Cheng Su(BioMarin Pharmaceutical Inc.)
Abstract
Individual chapters are listed in the "Chapters" tab
Suggested Citation
DOI: 10.1007/978-3-030-31503-0
Download full text from publisher
To our knowledge, this item is not available for download. To find whether it is available, there are three options:1. Check below whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a for a similarly titled item that would be available.
Book Chapters
The following chapters of this book are listed in IDEAS- M. Man & T. S. Nguyen & C. Battioui & G. Mi, 2019. "Predictive Subgroup/Biomarker Identification and Machine Learning Methods," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 1-22, Springer.
- G. Mi & W. Li & T. S. Nguyen, 2019. "Characterize and Dichotomize a Continuous Biomarker," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 23-38, Springer.
- Yongming Qu, 2019. "Surrogate Biomarkers," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 39-52, Springer.
- Jing Wang & Mark Chang, 2019. "Innovative Designs for Biomarker-Guided Trials," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 53-65, Springer.
- Meijuan Li & Rui Tang, 2019. "Statistical Considerations in the Development of Companion Diagnostic Device," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 67-86, Springer.
- Guang Chen & Shuguang Huang & Winnie Weng & Cheng Su, 2019. "Biomarker Assay Development, Qualification, and Validation," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 87-115, Springer.
- Yoonha Choi & Jing Huang, 2019. "Validation of Genomic-Based Assay," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 117-136, Springer.
- Ruixiao Lu & Rui Tang & Jing Huang, 2019. "Clinical Application of Molecular Features in Therapeutic Selection and Drug Development," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 137-166, Springer.
- Jing Lu & Yangyang Hao & Jing Huang & Su Yeon Kim, 2019. "Big Data, Real-World Data, and Machine Learning," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 167-195, Springer.
- Winnie Weng & Liang Fang, 2019. "Design and Analysis of Clinical Pharmacology Studies," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 197-220, Springer.
- Laurence Colin & Brian Smith, 2019. "Statistical Considerations in Proof-of-Concept Studies," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 221-245, Springer.
- Laurence Colin & Brian Smith, 2019. "Safety in Early Phase Studies," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 247-274, Springer.
- Liang Fang & Winnie Weng & Lu Wang & Xiaoru Wu, 2019. "Statistical Evaluation of QT/QTc Interval Prolongation," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 275-299, Springer.
- Qiqi Deng & Naitee Ting, 2019. "Phase II Dose Finding," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 301-320, Springer.
- Alan H. Hartford & Kenneth G. Kowalski, 2019. "Pharmacometrics," Springer Books, in: Liang Fang & Cheng Su (ed.), Statistical Methods in Biomarker and Early Clinical Development, pages 321-348, Springer.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprbok:978-3-030-31503-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.
Printed from https://ideas.repec.org/b/spr/sprbok/978-3-030-31503-0.html